The Western blot results proved that TASENN significantly inhibited the abnormal phosphorylation of Tau protein in the hippocampus and cortex of APP/PS1 transgenic AD mice and reduced the expression of CaM (Gou, 2019). Here, APP is linked to Alzheimer disease.